[Economic burden of Parkinson's disease in Japan: long-term care expenditure for PD patients].

Q4 Medicine Clinical Neurology Pub Date : 2024-11-21 DOI:10.5692/clinicalneurol.cn-002021
Ichiro Naoi, Hiroshi Aino
{"title":"[Economic burden of Parkinson's disease in Japan: long-term care expenditure for PD patients].","authors":"Ichiro Naoi, Hiroshi Aino","doi":"10.5692/clinicalneurol.cn-002021","DOIUrl":null,"url":null,"abstract":"<p><p>This study aims to quantify the economic burden of Parkinson's disease (PD) in Japan. We conducted a targeted literature review and extracted data on the direct medical costs and long-term care costs of PD patients based on their severity, as categorized by the Hoehn and Yahr (HY) disease severity scale. These costs were estimated using information from literature sources and governmental statistics. The mean annual long-term care costs for HY1 to 5 were estimated: JPY 333 433, 527 194, 982 578, 2 023 735, and 3 080 743, respectively. These estimates were based on a cross table of HY severity and designated grade of long-term care, which was extracted from a survey of PD patients in Tokyo conducted in 2017 and national statistics on long-term care expenditure per person in June 2023. Assuming that the number of PD patients in Japan is 200,000, the annual costs for direct medical, long-term care, and the total are estimated approximately JPY 380, 270, and 650 billion, respectively. These results suggest that PD requires a significant amount of long-term care resources.</p>","PeriodicalId":39292,"journal":{"name":"Clinical Neurology","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Neurology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5692/clinicalneurol.cn-002021","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

This study aims to quantify the economic burden of Parkinson's disease (PD) in Japan. We conducted a targeted literature review and extracted data on the direct medical costs and long-term care costs of PD patients based on their severity, as categorized by the Hoehn and Yahr (HY) disease severity scale. These costs were estimated using information from literature sources and governmental statistics. The mean annual long-term care costs for HY1 to 5 were estimated: JPY 333 433, 527 194, 982 578, 2 023 735, and 3 080 743, respectively. These estimates were based on a cross table of HY severity and designated grade of long-term care, which was extracted from a survey of PD patients in Tokyo conducted in 2017 and national statistics on long-term care expenditure per person in June 2023. Assuming that the number of PD patients in Japan is 200,000, the annual costs for direct medical, long-term care, and the total are estimated approximately JPY 380, 270, and 650 billion, respectively. These results suggest that PD requires a significant amount of long-term care resources.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
[日本帕金森病的经济负担:帕金森病患者的长期护理支出]。
本研究旨在量化帕金森病(PD)在日本造成的经济负担。我们进行了有针对性的文献综述,并根据帕金森病患者的严重程度(按 Hoehn and Yahr (HY) 疾病严重程度量表分类)提取了有关帕金森病患者直接医疗成本和长期护理成本的数据。这些费用是根据文献资料和政府统计数据估算的。根据估算,HY1 至 5 的平均年度长期护理成本分别为分别为 333 433 日元、527 194 日元、982 578 日元、2 023 735 日元和 3 080 743 日元。这些估算是根据 2017 年对东京都内的帕金森病患者进行的一项调查中提取的 HY 严重程度和指定的长期护理等级交叉表以及 2023 年 6 月的全国人均长期护理支出统计数据得出的。假设日本的帕金森病患者人数为 20 万,那么每年的直接医疗、长期护理和总费用估计分别约为 3 800 亿、2 700 亿和 6 500 亿日元。这些结果表明,帕金森病需要大量的长期护理资源。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Clinical Neurology
Clinical Neurology Medicine-Neurology (clinical)
CiteScore
0.30
自引率
0.00%
发文量
147
期刊最新文献
[Early diagnosis of a long spinal cord infarction lesion based on concurrent erector spinae muscle infarction: a case report]. [Economic burden of Parkinson's disease in Japan: long-term care expenditure for PD patients]. [Importance of early treatment and quantitative evaluation of enzyme replacement therapy for Pompe disease: alglucosidase alfa post-marketing surveillance additional analysis]. [Is the frequency of head MRI lesions reduced in Wernicke's encephalopathy associated with alcoholism?] [Is the frequency of head MRI lesions reduced in Wernicke's encephalopathy associated with alcoholism?]
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1